Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Näslund Salomonsson, B. Koch, L. Elfsmark, A. Bucht (Umeå, Sweden). Late Breaking Abstract: An animal model for studies on pathogenesis and pharmaceutical intervention of chronic asthma. Eur Respir J 2010; 36: Suppl. 54, 5646

Member's Comments

No comment yet.

Related content which might interest you: Late Breaking Abstract - A key endpoint in viral challenge models of asthma exacerbations Source: International Congress 2019 – Airway physiology Year: 2019 Late Breaking Abstract - ND-L02-s0201 treatment leads to efficacy in preclinical IPF models Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Late Breaking Abstract - Nationwide asthma management and disease control in primary versus secondary care – a real-world evidence study Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more Year: 2020 Late Breaking Abstract - iPREDICT: Pilot study to develop predictive model of changes in asthma control Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases Year: 2019 Late Breaking Abstract - Pharmacological and clinical management of severe asthma in 9 countries: An international survey of clinicians. Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Late Breaking Abstract - Defining a severe asthma super-responder: findings from a Delphi process Source: Virtual Congress 2020 – Advances in asthma treatment Year: 2020 Late Breaking Abstract - Reimbursement for asthma care is a universal barrier to achieving asthma symptom control: the SABINA III study Source: Virtual Congress 2020 – Personalised treatment of obstructive diseases Year: 2020 Omics in population studies: a molecular epidemiology perspective in chronic airway disease Source: International Congress 2014 – Personalised exposure and gene environment interactions in chronic airway disease: the exposome and epigenome Year: 2014 Late Breaking Abstract - Molecular mechanisms involved in early stage of pulmonary hypertension: experimental study Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension Year: 2018 Late Breaking Abstract - Patients with severe eosinophilic asthma benefit from the treatment with Anti-IL-5 Reslizumab – a real life study from Austria Source: International Congress 2018 – Notable Studies in Asthma Year: 2018 Applying the 3Rs to asthma research Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Late Breaking Abstract - Indacaterol/glycopyrronium versus salmeterol/fluticasone in chronic obstructive pulmonary disease: a meta-analysis on the protection against the risk of exacerbation Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Late Breaking Abstract - Estimating the relationship between environmental exposures and acute exacerbations of COPD Source: Virtual Congress 2021 – Occupational COVID-19 and respiratory infections Year: 2021 Late Breaking Abstract - Geographic accessibility and chronic respiratory disease outcomes: a decision support tool Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry Year: 2019 Late Breaking Abstract - The humanistic burden of asthma patients uncontrolled on ICS-LABA: a systematic literature review Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma Year: 2020 Evaluating COPD disease management: application of a theoretical model Source: Annual Congress 2008 - Issues in the management of COPD in the community Year: 2008 Late Breaking Abstract - International, prospective real-world study of mepolizumab in patients with severe asthma at one year: REALITI-A Source: Virtual Congress 2021 – Advances in asthma treatment Year: 2021 Late Breaking Abstract - Economics burden and healthcare utilization in chronic obstructive pulmonary disease patients with or without sepsis. Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness Year: 2019